Abstract
Neuromuscular blocking agents are widely used to produce relaxation of skeletal muscles during surgical operations. Since the introduction of curare into anaesthesia by Griffith and Johnson in 1942, anaesthetic practice has been completely revolutionised because there is now no longer the need to produce skeletal muscular relaxation by deep anaesthesia with the inherent risks involved.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bamford DG, Biggs DF, Davis M, Parness EW (1967) Neuromuscular blocking properties of stereoisomeric and androstane-3,17-bisquaternary ammonium salts. Br J Pharmacol 30:194–202
Biggs RS, Davis M, Wien R (1964) Muscle relaxant properties of a steroid bis-quaternary ammonium salt. Experientia 20:119–120
Bowman WC (1980) Pharmacology of neuromuscular function. Wright, Bristol, pp 109–115
Bowman WC, Nott MW (1969) Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev 21:27–72
Busfield D, Child KJ, Clark AJ, Davis B, Dodds MG (1968) Neuromuscular blocking activities of some steroidal mono and bis-quaternary ammonium compounds with special reference to N,N’-dimethyl conessine. Br J Pharmacol 32:609–623
Chapple DJ, Clark JS (1983) Pharmacological action of breakdown products of atracurium and related substances. Br J Anaesth 55:11–15S
Chapple DJ, Clark JS, Hughes R (1983) Interaction between atracurium and drugs used in anaesthesia. Br J Anaesth 55:17–22S
Docherty JR, McGrath JC (1977) Potentiation of cardiac sympathetic nerve response in vivo by pancuronium bromide. Br J Pharmacol 61:472P
Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Fogdall RP, Miller RD (1974) Prolongation of a pancuronium-induced neuromuscular blockade by polymyxin B. Anaesthesiology 40:84–87
Ginsborg BL, Warriner J (1960) The isolated chick biventer-cervicis nerve-muscle preparation. Br J Pharmacol 15:410–411
Griffith HR, Johnson GE (1942) the use of curare in general anaesthesia. Anesthesiology 3:418–420
Hughes R (1970) the influence of changes in acid base balance on neuromuscular blockade in cats. Br J Anaesth 42:658–668
Hughes R (1972) Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW252C64 and BW403C65). Br J Anaesth 44:27–42
Hughes R, Chappie DJ (1976 a) Effects of non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br J Anaesth 48:59–68
Hughes R, Chappie DJ (1976 b) Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetised cats and rhesus monkeys. Br J Anaesth 48:847–852
Hughes R, Chappie DJ (1981) the pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth 53:31–44
Hughes R, Payne JP (1979) Interactions of halothane with non-depolarizing neuromuscular blocking drugs in man. Br J Clin Pharmacol 7:485–490
Hughes R, Ingram GS, Payne JP (1976 a) Studies on dimethyl tubocurarine in anaesthetised man. Br J Anaesth 48:969–974
Hughes R, Payne JP, Sugai N (1976 b) Studies on fazadinium bromide (AH 8165), a new non-depolarizing neuromuscular blocking agent. Can Anaesth Soc J 23:36–47
Ivankovich AD, Miletich, Albrecht RF, Zahed B (1975) The effect of pancuronium on myocardial contraction and catecholamine metabolism. J Pharm Pharmacol 27:837–841
Iversen LL (1963) The uptake of noradrenaline by the isolated perfused heart. Br J Pharmacol 21:523–537
Lebowitz PW, Ramsey FM, Savarese JJ, Alli HH (1980) Potentiation of neuromuscular blockade in man produced by combination of pancuronium and metocurarine and pancuronium and d-tubocurarine. Anaesth Analg 59:604–609
Maclagan J (1976) Competitive blocking drugs. In: Zaimis E (ed) Neuromuscular junction. Springer, Berlin, p 421
Mushin WW, Mapleson WW (1964) Relaxant action in man of dipyrandium chloride (M&B 9105A). Br J Anaesth 36:761–768
Neill EAM, Chappie DJ (1982) Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pH. Xenobiotica 12:203–210
Neill EAM, Chappie DJ, Thompson CW (1983) the metabolism and kinetics of atracurium: an overview. Br J Anaesth 55:23–25S
Payne JP, Hughes R (1981) Evaluation of atracurium in anaesthetised man. Br J Anaesth 53:45–54
Pittinger C, Adamson R (1972) Antibiotic blockade of neuromuscular function. Ann Rev Pharmacol 12:169–184
Salt P, Barnes PK, Conway CM (1980) Inhibition of neuronal uptake of noradrenaline and its homologues, Org 6368, Org 7688 and NC 45. Br J Anaesth 52 Suppl:313–317
Sokoll MD, Gergis SD (1981) Antibiotics and neuromuscular function. Anesthesiology 55:148–159
Stenlake JB (1979) Ions-cyclic nucleotids-cholinergy. In: Stoclet JC (ed) Advances in pharmacology and therapeutics. Pergamon, Oxford, p 303
Wingard LB, Cook DR (1977) Clinical pharmacokinetics of muscle relaxants. Clin Pharmacokin 2:330–343
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hughes, R. (1986). Atracurium. In: Kharkevich, D.A. (eds) New Neuromuscular Blocking Agents. Handbook of Experimental Pharmacology, vol 79. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70682-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-70682-0_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70684-4
Online ISBN: 978-3-642-70682-0
eBook Packages: Springer Book Archive